In ABX-treated HTGAP mice, administration of A. mucilyticum exacerbated pancreatic inflammation, as demonstrated by elevated serum lipase levels (Figure 5B), increased pancreatic MPO activity (Figure 5C), and aggravated histological damage (Figure 5D). Here, MPO is linked to inflammation.